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AbstrAct Aim: As part of the Catania symposium on lung metastasectomy we reviewed 
our practice of computed tomography (CT)-guided percutaneous transthoracic needle 
biopsy of pulmonary metastatic lesions with particular emphasis on diagnostic accuracy 
and nature of complications lesions. materials & methods: 25 patients with metastatic 
lesions of the lung have been evaluated between May 2010 and February 2014. Inclusion 
criteria consisted of patients with histologically confirmed, metastatic disease of the lung, 
those receiving a CT-guided needle biopsy, were at least 18 years of age; and with adequate 
hepatic, renal and hematological function. We recorded also the size of the sampled 
lesions, their distance from the pleura, the complications encountered (pneumothorax and 
thoracostomy tube placement), the cytological diagnosis and the outcome in all the cases. 
Results: CT-guided percutaneous transthoracic needle biopsy were performed on 23 of 
25 patients with suspected lung metastases. 17 males and six females with a mean age of 
71.4 years. The mean size of lesions was 4.2 cm (range: 1 to 17 cm). For CT-guided needle 
biopsy, an 18 gauge semi-automatic needle biopsy device was used. Of 23 biopsies, 20 (87%) 
yielded a correct diagnosis with specific histological typing for metastasis. Pneumothorax 
was the most common complication occurring in four cases (5.7%). Conclusion: CT-guided 
percutaneous transthoracic needle biopsy is a firm, useful and safe technique for the 
diagnosis of suspected pulmonary metastases as it avoids open biopsy in most cases.
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It is known that the lungs are a common site for metastases from other primary cancers, such as breast, 
colon and sarcomas. Although in the patients with high-risk of lung metastasis the increasing utility of 
computed tomography (CT) low-dose screening has grown dramatically the sensitivity of identifying 
small lung nodules [1], CT-guided needle biopsy (CTgNB) of lung metastases (LM) with automatic 
or semi-automatic biopsy gun have proven to bring in diagnostic label with few  complications and is 
widely accepted as accurate and safe procedure for characterizing pulmonary nodules. [2]
Percutaneous transthoracic needle biopsy guided by CT is considered as a relatively well and safe 
method for diagnosing LM [3]. The rates of diagnostic accuracy have been documented between 72 
and 100% for pulmonary metastatic lesions. However, the diagnostic accuracy decrease for smaller 
lesions between 10 and 20 mm; several studies have reported the diagnostic accuracy range of 52 
and 96.5% [4,5].
The purpose of our study was to review our experience with CT-guided biopsy of suspected LM 
with a view to providing a critical assessment of the efficacy and safety of the procedure.
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materials & methods
Twenty-five patients with metastatic lesions of 
the lung larger than 3 cm have been evaluated 
between May 2010 and February 2014.
Inclusion criteria were patients with histologi-
cally confirmed cancer and suspected metastatic 
disease of the lung; 18 years of age and adequate 
hepatic, renal and hematological function.
Exclusion criteria were inadequacy of the sample 
taking, substantial medical comorbidities. Patients 
receiving warfarin or low-molecular-weight hepa-
rin were eligible, and were asked to stop warfarin 
therapy 1 week before the procedure and moni-
toring of prothrombin time and bleeding risks. 
Platelet counts of ≥1.0 × 109/ml and ≥50 × 106/ml, 
respectively, were required for biopsy.
Collected data included the patient’s age and 
gender, primary cancer, as well pathology record 
to the CTgNB, and the last available follow-up 
to evaluate the contingent periprocedural com-
plications. We recorded also the size of the sam-
pled lesions, their distance from the pleura, the 
complications encountered (pneumothorax and 
thoracostomy tube placement), the cytological 
diagnosis and the outcome in all the cases.
This single institutional retrospective study was 
approved by our institutional review board (IRB). 
All patients were required to provide a written 
informed consent before underwent a CTgNB in 
accordance with institutional guidelines.
Ct-guided procedure
The CT images at the time of biopsy were ret-
rospectively reviewed by two radiologist (AG 
and CG). A coaxial technique was performed 
in all the cases, and a single needle (18-gauge 
Menghini semi-automic cutting with coaxial 
technique) was used in all cases (100%), whereas 
different needles in combination were used when 
multiple samples had to be obtained.
The appropriate length of needles was chosen 
based on the depth of the lesion from the skin as 
measured by using the CT images. Needle biopsy 
was performed under guidance of a Multidetector 
CT on a 16 (Speedlight, GE Healthcare, WI, 
USA) slice scanner. Low-dose (120 kVp, 30 mA) 
CT images were obtained through the area of 
interest using a section thickness of 2.5–5 mm. 
Localization was determined by the CT gantry 
laser lights and grid on the skin. The skin entry 
site was sterilized, draped and local anesthesia 
was used.
After needle insertion, CT images were 
obtained at 1.5-mm section thicknesses to check 
the position of the needle tip. After confirma-
tion of adequate position of the needle tip, core 
biopsy were obtained and the CTgNB specimens 
transferred onto microscopy slides were read by 
a cytopathologist. After removal of the needle, 
a minimum dose CT of the thorax (120 kV, 
10 mA, 8-mm section thickness) was performed 
to assess for pneumothorax. Patients were sub-
sequently monitored by nurses in the Thoracic 
Surgery Department Day Unit.
Results
23 of 25 patients with suspected LM have been 
evaluated, between them two patients did not 
have biopsy because procedural difficulties and 
therefore 23 patients have been included in the 
study. There were 17 males and six females, 
with a mean age of 71.4 years (range: 54–87). 
In one patient, the biopsy was repeated because 
of inadequacy of the first sample. Six patients 
underwent open surgical wedge resection of the 
metastases, and 17 nonsurgical patients who had 
been followed up for at least 3 months.
Radiologically, the lesions appeared as a solid 
mass in 22 cases (95.6%) or a cystic mass in 
one (4.4%). The mean diameter of the lesion 
was 4.2 cm ranged from 1 to 17 cm (mean 
4.2 cm; SD ± 1.99). 13 lesions were located in 
the superior lobes (56.5%); nine lesions [39.1%] 
in the left superior lobe and four (17.4%) in the 
right superior lobe. Five lesions in the inferior 
lobes (21.7%), of those three were (13%) in 
the left lower lobe and two (8.6%) in the right 
lower lobe.
To calculate the diagnostic accuracy, all 
patients were included. In 20 (87%) out 23 biop-
sies, a correct diagnosis with specific histo logical 
typing for metastasis was made. The overall 
s ensitivity was 91.8%.
In the six operated patients diagnosis was 
confirmed and one extra nodule was found. 
Histology showed metastasis of colon cancer 
(CDX2 and CK20+) in nine patients, of car-
cinoma of the endometrium in five, sarcomas 
in five (one sarcomatoid carcinoma G-3, one 
leiomyosarcoma, two condrosarcomas) and 
 undifferentiated carcinoma in three.
Of the three negative patients, one had the 
final diagnosis of inflammatory bronchiolitis 
disease and a second patient had a diagnosis of 
Langherans Cell Histiocytosis. Pneumothorax 
was the most common complication and 
occurred in four cases (17.4%), no hemorrhage 
was recorded.
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Figure 1. unenhanced computed tomography axial scan in a 65-year-old male. A large mass 
is adjacent to the left pleura. The tip of the needle is well visible inside the mass. The histological 
examination proved the lesion to be lung metastases of colon adenocarcinoma.
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Discussion
Metastatic disease is the main cause of death owing 
to cancer, and the lung is a common site of distant 
metastases [6]. When a new nodule appears in the 
lung in patients with operated primary tumor, 
cancer progression is generally thought and defi-
nite diagnosis is mandatory to determine whether 
the lesion is malignant or benign. Even when a 
lesion appears to be either malignant or benign on 
radiography, histological specimens should con-
firm the final diagnosis [7]. Preoperative diagnosis 
is in fact standard practice but is also a mandatory 
to include patients in prospective randomized trial 
that have the goal to demonstrate the effectiveness 
of lung biopsy for metastasis [8–11].
CT-guided biopsy represents therefore an 
important step to establish the diagnosis, and 
MDCT is superior to conventional radiography 
for detecting small pulmonary metastasis.
The CTgNB system provides microhisto-
logical samples to confirm the diagnosis of 
LM, which is crucial for planning an appropri-
ate treatment. Because most of our cases have a 
large metastases (mean size is above 4 cm) the 
diagnostic accuracy has been high [12]. Moreover, 
the preoperative diagnosis of large mass (Figure 1) 
suspected for LM is of paramount importance as 
extended operations for LM have been reported 
with poor outcome [13]. We performed open sur-
gical resection as in absence of proved advantage 
of one open versus VATS metastasectomy [4,14], 
we prefer to palpate all the lung to search for 
extra nodules.
In our small experience we reveal that the most 
common histology of secondary tumors were 
colon adenocarcinoma and pneumothorax was 
the most common complication occurring in 17% 
(95% CI: 7–37%) of our patients which is within 
the 5–65% reported incidence in the literature.
A recent study on 15.865 adults who had 
transthoracic needle biopsy of a pulmonary nod-
ule showed that the risk for any pneumothorax 
was 15.0% (CI: 14.0–16.0%), and 6.6% (CI: 
6.0–7.2%) of all biopsies resulted in pneumotho-
rax requiring a chest tube [15]. On the contrary, we 
did not insert chest drains but again our experi-
ence is small. The fact that the rate of pneumo-
thorax in our experience is so low is probably due 
to the fact that the biopsied lesions are large and 
most adherent to the chest wall.
Only in two patients we have performed open 
biopsy to reach the diagnosis.
Conclusion
CT-guided percutaneous transthoracic needle 
biopsy is a firm, useful and safe technique for the 
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